Back

A Longitudinal Study of Executive Function in Daily Life in Male Fragile X Premutation Carriers and Association with FXTAS Conversion

Hessl, D.; Mandujano, K.; Ferrer, E.; Espinal, G.; Famula, J.; Schneider, A.; Hagerman, R.; Tassone, F.; Rivera, S.

2023-09-02 psychiatry and clinical psychology
10.1101/2023.08.31.23294855 medRxiv
Show abstract

BackgroundMen with fragile X-associated tremor/ataxia syndrome (FXTAS) often develop executive dysfunction, characterized by disinhibition, frontal dyscontrol of movement, and working memory and attention changes. Although cross-sectional studies have suggested that earlier executive function changes may precede FXTAS, the lack of longitudinal studies have made it difficult to address this hypothesis. MethodsThis study included 66 FMR1 premutation carriers (PC) ranging from 40-78 years (Mean=59.5) and 31 well-matched healthy controls (HC) ages 40-75 (Mean 57.7) at baseline. Eighty-four participants returned for 2-5 follow up visits over a duration of 1 to 9 years (Mean=4.6); 28 of the PC developed FXTAS. The Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) was completed by participants and their spouses/partners at each visit. ResultsLongitudinal mixed model regression analyses showed a greater decline with age in PC compared to HC on the Metacognition Index (MI; self-initiation, working memory, organization, task monitoring). Conversion to FXTAS was associated with worsening MI and Behavioral Regulation Index (BRI; inhibition, flexibility, emotion modulation). For spouse/partner report, FXTAS conversion was associated with worsening MI. Finally, BRIEF-A executive function problems at baseline significantly predicted later development of FXTAS. ConclusionsThese findings suggest that executive function changes represent a prodrome of the later movement disorder.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Neurology Genetics
15 papers in training set
Top 0.1%
9.7%
2
PLOS ONE
5266 papers in training set
Top 22%
7.9%
3
Parkinsonism & Related Disorders
25 papers in training set
Top 0.1%
6.3%
4
Journal of Neurology, Neurosurgery & Psychiatry
30 papers in training set
Top 0.1%
5.6%
5
Movement Disorders
71 papers in training set
Top 0.3%
5.5%
6
NeuroImage: Clinical
144 papers in training set
Top 0.7%
4.1%
7
Neurobiology of Disease
148 papers in training set
Top 0.9%
4.1%
8
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
71 papers in training set
Top 0.6%
2.8%
9
Journal of Neurogenetics
11 papers in training set
Top 0.1%
2.8%
10
Journal of Parkinson’s Disease
12 papers in training set
Top 0.1%
2.7%
50% of probability mass above
11
Frontiers in Neurology
102 papers in training set
Top 1%
2.5%
12
GeroScience
109 papers in training set
Top 1%
2.0%
13
Journal of Alzheimer’s Disease
50 papers in training set
Top 0.7%
2.0%
14
Journal of Neurodevelopmental Disorders
17 papers in training set
Top 0.2%
1.9%
15
Cells
249 papers in training set
Top 3%
1.7%
16
Brain Communications
166 papers in training set
Top 2%
1.7%
17
The Cerebellum
17 papers in training set
Top 0.1%
1.7%
18
Journal of Alzheimer's Disease
48 papers in training set
Top 0.7%
1.5%
19
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.3%
20
Behavioural Brain Research
77 papers in training set
Top 1.0%
1.3%
21
Neurology
50 papers in training set
Top 1%
1.1%
22
Scientific Reports
3612 papers in training set
Top 68%
1.1%
23
International Journal of Molecular Sciences
494 papers in training set
Top 12%
1.1%
24
BMJ Open
601 papers in training set
Top 12%
1.0%
25
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
42 papers in training set
Top 0.8%
1.0%
26
Frontiers in Aging Neuroscience
74 papers in training set
Top 1%
1.0%
27
Brain Sciences
55 papers in training set
Top 2%
0.8%
28
Genes
144 papers in training set
Top 4%
0.8%
29
Brain
168 papers in training set
Top 3%
0.8%
30
Molecular Psychiatry
282 papers in training set
Top 5%
0.8%